Skip to main content

PREVDUO

NDC 42023-269 · Endo USA

Generic nameneostigmine methylsulfate and glycopyrrolate
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)NEOSTIGMINE METHYLSULFATE, GLYCOPYRROLATE
Strength.2; 1 mg/mL; mg/mL
Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
Marketing categoryNDA

Packages

42023-269-05 — 5 SYRINGE, PLASTIC in 1 CARTON (42023-269-05) / 3 mL in 1 SYRINGE, PLASTIC (42023-269-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

23155-606 — Glycopyrrolate, 23155-607 — Glycopyrrolate, 25021-610 — Neostigmine Methylsulfate, 25021-611 — Neostigmine Methylsulfate, 25021-796 — Glycopyrrolate, 31722-016 — Glycopyrrolate, 31722-994 — neostigmine methylsulfate, 31722-995 — neostigmine methylsulfate, 42023-188 — NEOSTIGMINE METHYLSULFATE, 42023-189 — NEOSTIGMINE METHYLSULFATE, 43547-543 — glycopyrrolate, 43547-544 — glycopyrrolate, 43547-639 — glycopyrrolate, 43547-640 — glycopyrrolate, 43598-528 — Neostigmine, 43598-529 — Neostigmine, 43598-945 — Neostigmine Methylsulfate, 49884-042 — Glycopyrrolate, 49884-065 — glycopyrrolate, 49884-066 — glycopyrrolate, +229 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels